News

December 6, 2011 — Boston Scientific Corp. announced U.S. Food and Drug Administration (FDA) approval of its Incepta, Energen and Punctua cardiac resynchronization therapy defibrillators (CRT-Ds)...

November 16, 2011 — MedSolutions announced the launch of its Implantable Cardioverter Defibrillator (ICD) Surgery Management Program. The system uses evidence-based guidelines to ensure the...

September 12, 2011 — Cardiovascular market research firm Zacks Equity Research released a new report discussing high growth areas in medical devices, including Medtronic Inc., Boston Scientific...

September 1, 2011 – St. Jude Medical Inc. announced the first insertion of an implantable cardioverter defibrillator (ICD) as part of a United States clinical study. The trial will examine the...

Canada is spearheading an international study to determine if an implantable cardioverter defibrillator (ICD) can prevent death from serious heart rhythm problems in those patients who’ve survived...

May 10, 2011 – The world's smallest and thinnest high-energy cardiac resynchronization therapy defibrillators (CRT-Ds) and implantable cardioverter defibrillators (ICDs) to treat heart failure and...
May 6, 2011 – New data presented at the Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions are the first to look at the use of highly specialized signals within...
May 6, 2011 – Results from an analysis of the ALTITUDE Clinical Science program demonstrated that defibrillator therapy saves lives from lethal arrhythmias without an increase in mortality due to...

March 4, 2011 – According to a retrospective sub-study of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), there is no evidence that implantable cardioverter defibrillator (ICD) benefit...

March 1, 2011 – Medtronic, St. Jude Medical and Biotronik have emerged as leaders in the €2.8 billion European cardiac rhythm management (CRM) electrophysiology and ablation market, according to...

February 10, 2011 – Never before has a therapy proven more beneficial for women than men in preventing heart disease – until now.

February 1, 2011 – Despite the benefits of therapy with implantable cardioverter-defibrillators (ICDs), inappropriate shocks from the devices are common and place patients at a greater mortality...

January 28, 2011 – The Civil Division of the U.S. Department of Justice (DOJ) filed a civil False Claims Act lawsuit against Boston Scientific, Guidant LLC and other entities seeking additional...

January 24, 2011 – Boston Scientific has reached an agreement with Fukuda Denshi to market and sell its cardiac rhythm management (CRM) devices and accessories throughout Japan. Fukuda Denshi will...

December 29, 2010 - Research on reducing risks, improving medical treatment and improving lifestyle behaviors to fight the battle against heart disease and stroke are among the key scientific...

October 29, 2010 – Site enrollment has been completed for the 50-site CITADEL and CENTURION clinical studies to evaluate the Tyrx AigisRx Antibacterial Envelope. The device is designed to help...

October 20, 2010 – New study results show that patients undergoing cardiac implantable electronic device (CIED) implantation had a 99.5 percent rate of successful implantation with an overall...

October 5, 2010 – Data from a prospective study show physicians may benefit from knowing complication rates associated with pacemaker or implantable cardioverter defibrillator (ICD) generator...

October 4, 2010 – Long-term data from a clinical trial studying the benefits of implantable cardioverter defibrillator (ICD) therapy have been published in Circulation.

September 28, 2010 - Software downloaded during a routine office visit cuts the risk of inappropriate shocks by 50 percent for patients with implantable cardioverter defibrillators (ICD),...